Orphan Drug

Drugs that aren't developed by the pharmaceutical business for economic reasons however that answer public health want. Orphan drugs' area unit supposed to treat diseases therefore rare that sponsors area unit reluctant to develop them below regular promoting conditions. the method from the invention of a replacement molecule to its promoting is long, high-priced and really unsure. Developing a drug expecting to treat a rare sickness doesn't permit the recovery of the capital invested with for its analysis.

 

    Related Conference of Orphan Drug

    September 11-12, 2023

    21st European Pathology Congress

    Paris, France
    October 16-17, 2023

    21st Annual Pathology Congress

    London, UK

    Orphan Drug Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in